Ginkgo Bioworks Holdings (MEX:DNA) Unearned Premiums

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:DNA Ginkgo Bioworks Holdings Inc MEX:DNA
42 GF Score
Price MXN170.00
GF Value MXN127.55
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Ginkgo Bioworks Holdings Unearned Premiums?

Unearned Premiums only applies to insurance companies.

MEX:DNA
42GF Score
Ginkgo Bioworks Holdings Inc MEX:DNA
Unearned Premiums is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ginkgo Bioworks Holdings (MEX:DNA) Overvalued in 2026?

Based on GuruFocus' analysis, Ginkgo Bioworks Holdings stock appears to be overvalued. The current stock price of MXN170.00 is trading 33.3% above its estimated GF Value™ of MXN127.55. GuruFocus considers Ginkgo Bioworks Holdings to be Significantly Overvalued.

Key valuation signals for MEX:DNA:

  • Unearned Premiums:
  • GF Value™: MXN127.55 vs. price of MXN170.00 (33.3% above fair value)
  • GF Score™: 42/100 with 5 warning signs

No single metric tells the full story. See the MEX:DNA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ginkgo Bioworks Holdings Business Description

Other Exchanges DNA:USA
Address 27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
42GF Score

Get the complete analysis for MEX:DNA

Unearned Premiums is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN170.00
Price
MXN127.55
GF Value